Clinical Trial Update: Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding certolizumab pegol to chemotherapy and nivolumab for lung cancer that can be treated surgically; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Lung Cancer Stage II | Phase 2 | Status: RECRUITING